GL1X · GenesisL1 explorer

Research workbench

Structure of HCV NS5B bound to an anthranilic acid inhibitor

Analyse Structure of HCV NS5B bound to an anthranilic acid inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2QE2
Type
protein
Length
1,044 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
RNA-directed RNA polymerase
EC
2.7.7.48
UniProt
Q99AU2
Ligands
452
Pockets
15 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 51% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARNA-directed RNA polymerase (EC 2.7.7.48)protein52150% helix, 15% strandQ99AU2
BRNA-directed RNA polymerase (EC 2.7.7.48)protein52351% helix, 15% strandQ99AU2

Ligands and binding sites

  • 452 · 2-{[N-(2-acetyl-5-chloro-4-fluorophenyl)glycyl]amino}benzoic acid · ligand · 2 copies · chains B, A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

15 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111080.800.8191452
29730.790.8182452
39940.780.8078empty
4980.480.8020empty
5620.470.8413empty

Interfaces

1 interface between chains.

  • A–B · 646 Ų buried · 16 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 2QE2 · Structure of HCV NS5B Bound to an Anthranilic Acid Inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.